Intraperitoneal injection of recombinant IL11 (reIL11) in tumor-bearing Il11−/− mice boosted tumor growth, while STAT3 knockdown diminished such pro-tumor effect in vivo (Fig. 4D–F). This evidence concerns the gene IL11 and neoplasm.